Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18381930 | POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17742390 | COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME | Non-Final OA | FUJIFILM Corporation |
| 17761508 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES | Final Rejection | Purdue Research Foundation |
| 19232766 | APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION | Final Rejection | GE HEALTHCARE LIMITED |
| 19232774 | METHOD FOR PREPARING AN [18F] RADIOLABELLED COMPOUND WITH LOW WATER CONTENT DURING LABELLING STEP | Final Rejection | GE HealthCare, Inc. |
| 17641417 | ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE | Final Rejection | The Johns Hopkins University |
| 18257974 | ISOCYCLOSERAM FORMULATION | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 17927917 | NON-INVASIVE AND LONGITUDINAL MONITORING OF MICROGLIAL ACTIVATION IN RAT BRAIN WITH SUPERMAGNETIC NANOPARTICLE ENHANCED MR IMAGING | Non-Final OA | UNM RAINFOREST INNOVATIONS |
| 17588458 | MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 17253307 | TRIAZAMACROCYCLE-DERIVED CHELATOR COMPOSITIONS FOR COORDINATION OF IMAGING AND THERAPY METAL IONS AND METHODS OF USING SAME | Non-Final OA | The Research Foundation for The State University of New York |
| 17627673 | THERANOSTIC CONJUGATES | Final Rejection | Ariel Scientific Innovations Ltd. |
| 18241277 | SURGICAL VISUALIZATION AND MEDICAL IMAGING DEVICES AND METHODS USING NEAR INFRARED FLUORESCENT POLYMERS | Final Rejection | University of Rochester |
| 16876109 | METHOD OF DELIVERING DRUGS TO INNER EAR FACILITATED BY MICROBUBBLES | Final Rejection | National Taiwan University of Science and Technology |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | Non-Final OA | UNIVERSITY OF COPENHAGEN |
| 17998712 | NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY | Final Rejection | UNIVERSITY OF COPENHAGEN |
| 17574790 | Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents | Non-Final OA | Virginia Commonwealth University |
| 17632438 | ADDITIONAL MASS TAG POLYMERS FOR MASS CYTOMETRY | Final Rejection | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO |
| 18246706 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | Final Rejection | ORANO MED |
| 18254565 | NERVE TARGETING PEPTIDES AND METHODS OF USE | Non-Final OA | ALUME BIOSCIENCES, INC. |
| 16998587 | TARGETED FLUORESCENT MARKERS IN COMBINATION WITH A FLEXIBLE PROBE | Final Rejection | On Target Laboratories, LLC |
| 18116976 | Methods and Apparatuses for the Synthesis of Drug-Loaded Magnetic Micelle Aggregates | Non-Final OA | Imagion Biosystems, Inc. |
| 18023526 | TUMOR CONTRAST COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN TUMOR DIAGNOSTIC IMAGING | Non-Final OA | Zhejiang Haibo Biotech, Co., Ltd. |
| 18040011 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | Non-Final OA | Paul Scherrer Institut |
| 18158427 | METHODS AND SYSTEMS FOR SPATIALLY IDENTIFYING ABNORMAL CELLS | Non-Final OA | Lumicell, Inc. |
| 17995963 | COMPOUND, CONTRAST AGENT, AND METHOD FOR PRODUCING COMPOUND | Final Rejection | SOPHIA SCHOOL CORPORATION |
| 17935084 | MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY | Final Rejection | Antelope Surgical Solutions, Inc. |
| 17892739 | RADIOIMMUNOCONJUGATE FOR USE IN TREATING BONE MARROW ASSOCIATED DISEASES | Non-Final OA | TheraPharm GmbH |
| 17280137 | CD8 IMAGING CONSTRUCTS AND METHODS OF USE THEREOF | Non-Final OA | ImaginAb, Inc. |
| 17752104 | COMPOSITION FOR ULTRASOUND CONTRAST AGENT, ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | Non-Final OA | Nanjing Leapsonics Technology Co., Ltd. |
| 17769693 | NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF | Final Rejection | Manzanita Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy